NITO
Nexentis Technologies Inc.
Key Financials
Operating Income
$-4230000
↑ 2.1%
Gross Profit
$45000
↓ 78.4%
Net Income
$-4004000
↑ 22.9%
Revenue
$210000
↓ 20.3%
Total Liabilities
$4.7M
↑ 424.1%
EPS (Diluted)
$-8.61
↓ 867.4%
Total Assets
$20.4M
↑ 273.4%
Cash & Equivalents
$3.8M
↑ 75.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B5 | 6/23/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 424B5 | 6/15/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 8-K | 5/27/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| EFFECT | 4/29/2026 | View on SEC |
| CORRESP | 4/28/2026 | View on SEC |
| UPLOAD | 4/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NITO |
| Company Name | Nexentis Technologies Inc. |
| CIK | 1789192 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 972544561349 |